EUVIMEDEUVIMED entdecken
Crossref

Efficacy and safety of nintedanib in elderly patients with progressive fibrosing interstitial lung diseases (ILDs)*

F Bonella, T Moua, M Okamoto, S Tomassetti, C Valenzuela, W Wuyts, C Miede, D Lievens, E Bendstrup

Pneumologie · 01.03.2023 · 77 (S 01 S 01) · S57

DOI: 10.1055/s-0043-1761002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pneumologie, erschienen am 01.03.2023. Verfasst von F Bonella und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Elderly ILD patients are more likely to be frail and to have comorbidities that complicate their care. We investigated the efficacy and safety of nintedanib in elderly patients with progressive fibrosing (PF-) ILDs other than idiopathic pulmonary fibrosis (IPF) in the INBUILD trial ([ Abb. 1 ]). Abb. 1 Rate of decline in FVC (m/year) over 52 weeks in the INBUILD trial in subgroups by age at baseline.

Methods

Patients had a chronic fibrosing ILD other than IPF, reticular abnormality with traction bronchiectasis (with/without honeycombing) of>10% on HRCT, and met criteria for ILD progression within the 24 months before screening, despite management deemed appropriate in clinical practice. Patients were randomized to nintedanib or placebo. We analyzed the rate of decline in FVC (mL/year) over 52 weeks in subgroups by age

Zitieren

APA

Bonella, F., Moua, T., Okamoto, M., Tomassetti, S., Valenzuela, C., Wuyts, W., Miede, C., Lievens, D., & Bendstrup, E. (2023). Efficacy and safety of nintedanib in elderly patients with progressive fibrosing interstitial lung diseases (ILDs)*. Pneumologie, 77(S 01 S 01), S57. https://doi.org/10.1055/s-0043-1761002

Vancouver

Bonella F, Moua T, Okamoto M, Tomassetti S, Valenzuela C, Wuyts W, et al. Efficacy and safety of nintedanib in elderly patients with progressive fibrosing interstitial lung diseases (ILDs)*. Pneumologie. 2023;77(S 01 S 01):S57. doi:10.1055/s-0043-1761002

BibTeX
@article{Bonella2023,
  author = {Bonella, F and Moua, T and Okamoto, M and Tomassetti, S and Valenzuela, C and Wuyts, W and Miede, C and Lievens, D and Bendstrup, E},
  title = {Efficacy and safety of nintedanib in elderly patients with progressive fibrosing interstitial lung diseases (ILDs)*},
  journal = {Pneumologie},
  year = {2023},
  volume = {77},
  number = {S 01 S 01},
  pages = {S57},
  doi = {10.1055/s-0043-1761002}
}
Kostenlos starten →